🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to learn the safety, tolerability and ph...
Status
Recruiting
Location
Nucleus Network Pty Ltd.
Start Date
2026-02-06
Trial ID
NCT07262281
Treatments Being Tested
A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Orally Adm...
Status
Completed
Location
Labcorp Cru
Start Date
2022-08-08
Trial ID
NCT05349097
Treatments Being Tested
Phase 1, randomised, double-blind, placebo-controlled study of NaQuinate in...
Status
Unknown
Location
Parexel Early Phase Clinical Unit - London
Start Date
2019-06-18
Trial ID
NCT04036617
A randomized, double-blind, placebo-controlled trial design was used to ass...
Status
Unknown
Location
The Affiliated Hospital of Qingdao University
Start Date
2022-06
Trial ID
NCT05409326
Treatments Being Tested
A Phase I, single-center, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT02819687
To evaluate the safety and tolerance of single and multiple administrations...
Status
Active Not Recruiting
Location
Shenzhen People's Hospital
Start Date
2023-01-10
Trial ID
NCT07030504
Treatments Being Tested
This first in human phase 1 study to Study will evaluate safety, tolerabili...
Status
Withdrawn
Location
SCIENTIA Clinical Research Ltd
Start Date
2023-10-17
Trial ID
NCT06045624
Treatments Being Tested
To evaluate the safety and tolerability of single and multiple ascending do...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2018-05-15
Trial ID
NCT03530917
This is a randomized, double-blind, placebo-controlled, single- and multipl...
Status
Terminated
Location
First OC Dermatology Research
Start Date
2023-05-10
Trial ID
NCT05859724
To Evaluate the Safety, Tolerability and Pharmacokinetics on GST-HG171 Tabl...
Status
Completed
Location
The first hospital of Jilin University
Start Date
2022-10-01
Trial ID
NCT05668897
Treatments Being Tested